ARMK vs ASR

ARMK's deterministic health signals are concerning, with a Piotroski F-Score of 4/9 indicating marginal financial stability and no available Altman Z-Score to confirm solvency safety. The stock trades at a significant premium to its Graham Number of $18.06 and intrinsic value of $8.47, supported by strong revenue growth and analyst optimism, but profitability and earnings trends are inconsistent. While the company shows top-line momentum and operates efficiently relative to peers in a highly leveraged sector, weak margins, declining earnings, and technical bearishness temper enthusiasm. Analysts recommend a 'buy', yet insider sentiment and trading activity are neutral, suggesting no strong conviction from insiders.

ASR exhibits strong financial health with a Piotroski F-Score of 7/9, indicating solid operational and balance sheet strength. Profitability metrics are robust, with high margins and ROE above sector average, while leverage remains low. However, recent earnings declines and poor earnings surprise trends—four consecutive misses with double-digit negative surprises—raise concerns about near-term execution. The stock trades significantly above the Graham Number of $64.05, reflecting premium valuation despite weak earnings growth, though it aligns more closely with the growth-based intrinsic value of $181.09.